| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Radiology, Nuclear Medicine & Medical Imaging |
| Manuscript Type |
Retrospective Study |
| Article Title |
Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Alessandro Serafini, Valeria Ruggeri, Riccardo Inchingolo, Marco Gatti, Alessia Guarneri, Cesare Maino, Davide Ippolito, Luigi Grazioli, Umberto Ricardi and Riccardo Faletti |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Riccardo Inchingolo, MD, Chief Doctor, Director, Director, Doctor, Doctor, Interventional Radiology Unit, Miulli Hospital, Strada per Santeramo, Acquaviva delle fonti 70124, Italy. riccardoin@hotmail.it |
| Key Words |
Hepatocellular carcinoma; Stereotactic body radiation therapy; Magnetic resonance imaging; Histopatology; Outcome; Radiology |
| Core Tip |
As part of a retrospective study, 49 patients, who underwent SBRT for HCC between January 2013 and November 2019, were recruited. Each patient underwent a pre-treatment MRI examination with hepatospecific contrast agent and a similar follow-up examination within 6 months of therapy. In addition, 22 patients underwent a second follow-up examination after the first 6 months. The study results show that efficacy of SBRT should be evaluated not in the first 6 months, but at least 9 months post-SBRT, when infield progression persists at very low rates while the risk of outfield progression increases significantly. |
| Publish Date |
2022-09-23 00:48 |
| Citation |
Serafini A, Ruggeri V, Inchingolo R, Gatti M, Guarneri A, Maino C, Ippolito D, Grazioli L, Ricardi U, Faletti R. Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma. World J Hepatol 2022;14(9): 1790-1803 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i9/1790.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i9.1790 |
